z-logo
open-access-imgOpen Access
Myeloperoxidase as prognostic factor for atrial fibrillation development in patients with ST-segment elevation myocardial infarction
Author(s) -
I Rodionova,
I. Kutya,
Y.V. Hilova,
Y. Samburg,
Olga Godlevska,
N.V. Tytarenko
Publication year - 2022
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euac053.597
Subject(s) - medicine , myeloperoxidase , atrial fibrillation , myocardial infarction , cardiology , adverse effect , inflammation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom